ALLMedicine™ Tractional Retinal Detachment Center

Mar 14th, 2023 - Background Anytime subretinal fluid accumulates in the space between the neurosensory retina and the underlying retinal pigment epithelium (RPE), a retinal detachment occurs. Depending on the mechanism of subretinal fluid accumulation, retinal det...

Mar 14th, 2023 - Background Anytime subretinal fluid accumulates in the space between the neurosensory retina and the underlying retinal pigment epithelium (RPE), a retinal detachment occurs. Depending on the mechanism of subretinal fluid accumulation, retinal det...

Mar 14th, 2023 - Background Anytime subretinal fluid accumulates in the space between the neurosensory retina and the underlying retinal pigment epithelium (RPE), a retinal detachment occurs. Depending on the mechanism of subretinal fluid accumulation, retinal det...

Feb 24th, 2023 - Diabetic retinopathy (DR) is characterised by neurovascular degeneration as a result of chronic hyperglycaemia. Proliferative diabetic retinopathy (PDR) is the most serious complication of DR and can lead to total (central and peripheral) visual l...

Feb 22nd, 2023 - Background and Rationale: Diabetic retinopathy (DR) is a leading cause of blindness among the working age group with increasing numbers of persons being affected worldwide. The microvascular complications of diabetes result in macular leakage or e...

Feb 22nd, 2023 - Background and Rationale: Diabetic retinopathy (DR) is a leading cause of blindness among the working age group with increasing numbers of persons being affected worldwide. The microvascular complications of diabetes result in macular leakage or e...

Feb 15th, 2023 - Retinal vascularization in humans develops between the 16th and 36th week of amenorrhea, centrifugally from the papilla. In case of premature birth, the immature retinal periphery is at risk of ischemia due to lack of vascular development. This la...

Oct 31st, 2022 - Type of the study: A prospective comparative study. Study Setting: Assiut university hospital. Study subjects: Inclusion criteria: Patients suffering from different vitreo-retinal disorders (rhegmatogenous retinal detachment, diabetic vitreous hem...

Aug 31st, 2022 - Pars-plana vitrectomy (PPV) is the cornerstone of surgical treatment of complicated proliferative diabetic retinopathy allowing the removal of vitreous opacity and releasing tractions from the retina. Surgical outcomes, however, are variable depen...

Jul 28th, 2022 - The enrolled eyes were randomly assigned according to the Central Randomization System with a ratio of 1∶1 to IVA group and control group. Patients in IVA group received an IVA (0.5 mg/0.05 ml) injection before surgery (1 to 5 days before surgery)...

Dec 7th, 2022 - There is no increased risk of tractional retinal detachment (TRD) associated with anti-VEGF (vascular endothelial growth factor) intravitreal injection only, compared with laser-only therapy, nor with 6 months or longer of loss to follow-up in pat...

Dec 30th, 2020 - In the treatment of vitreous hemorrhage from proliferative diabetic retinopathy, intraocular injection with anti–vascular endothelial growth factor (VEGF) shows similar efficacy to that of vitrectomy with photocoagulation; however, patients common...

Jan 10th, 2019 - Treatment with statins was associated with a significantly decreased risk of diabetic retinopathy in patients with type 2 diabetes and high cholesterol in a large cohort study from Taiwan. Statin therapy was also associated with a lower need for i...

Oct 3rd, 2017 - One expert describes promising strategies for treating diabetic eye disease. A recent study provides new insights into how to prevent tractional retinal detachment from developing or progressing in patients with severe proliferative diabetic retin...

Mar 23rd, 2017 - Action Points Many youths with type 1 and type 2 diabetes are not being screened for diabetic retinopathy in accordance with current guidelines. Note that sociodemographic factors also played a role in screening patterns, with minority youth repor...